China Pharma Holdings (CPHI) Assets: 2009-2025
Historic Assets for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $15.8 million.
- China Pharma Holdings' Assets rose 17.37% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 17.37%. This contributed to the annual value of $14.9 million for FY2024, which is 9.60% down from last year.
- Per China Pharma Holdings' latest filing, its Assets stood at $15.8 million for Q3 2025, which was up 14.81% from $13.8 million recorded in Q2 2025.
- China Pharma Holdings' 5-year Assets high stood at $22.6 million for Q4 2021, and its period low was $13.5 million during Q3 2024.
- Over the past 3 years, China Pharma Holdings' median Assets value was $15.4 million (recorded in 2023), while the average stood at $15.2 million.
- In the last 5 years, China Pharma Holdings' Assets declined by 21.48% in 2022 and then increased by 17.37% in 2025.
- China Pharma Holdings' Assets (Quarterly) stood at $22.6 million in 2021, then dropped by 21.48% to $17.8 million in 2022, then fell by 7.39% to $16.5 million in 2023, then decreased by 9.60% to $14.9 million in 2024, then grew by 17.37% to $15.8 million in 2025.
- Its Assets was $15.8 million in Q3 2025, compared to $13.8 million in Q2 2025 and $14.2 million in Q1 2025.